IL32 and allergic disease: However, our findings that NK-4 inhibited IL-4 and IL-5 secretion by Th2 cells through down-regulating GATA-3 and NFATc1 mRNA expression suggest that NK-4 could be an effective strategy for the treatment of Th2-mediated allergic disease.